LTFS
WST icon

Ladenburg Thalmann Financial Services’s West Pharmaceutical WST Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$976K Buy
6,620
+926
+16% +$135K 0.01% 1305
2019
Q3 		$806K Buy
5,694
+1,665
+41% +$229K 0.01% 1395
2019
Q2 		$503K Buy
4,029
+584
+17% +$68.9K ﹤0.01% 1743
2019
Q1 		$380K Sell
3,445
-1,376
-29% -$143K ﹤0.01% 1898
2018
Q4 		$474K Buy
4,821
+2,303
+91% +$250K ﹤0.01% 1565
2018
Q3 		$311K Sell
2,518
-438
-15% -$49.1K ﹤0.01% 1967
2018
Q2 		$260K Hold
2,956
– – ﹤0.01% 2026
2018
Q1 		$260K Buy
2,956
+226
+8% +$21.1K ﹤0.01% 2026
2017
Q4 		$269K Buy
2,730
+106
+4% +$10.4K ﹤0.01% 1985
2017
Q3 		$253K Sell
2,624
-103
-4% -$9.32K ﹤0.01% 1923
2017
Q2 		$259K Sell
2,727
-257
-9% -$23.6K ﹤0.01% 1832
2017
Q1 		$245K Buy
2,984
+39
+1% +$3.26K ﹤0.01% 1766
2016
Q4 		$250K Buy
2,945
+210
+8% +$16.5K ﹤0.01% 1662
2016
Q3 		$203K Buy
2,735
+82
+3% +$6.51K ﹤0.01% 1745
2016
Q2 		$201K Buy
2,653
+121
+5% +$8.81K ﹤0.01% 1682
2016
Q1 		$175K Sell
2,532
-22
-0.9% -$1.32K ﹤0.01% 1696
2015
Q4 		$153K Sell
2,554
-247
-9% -$14.9K ﹤0.01% 1763
2015
Q3 		$152K Sell
2,801
-70
-2% -$4.08K ﹤0.01% 1693
2015
Q2 		$167K Sell
2,871
-81
-3% -$4.52K ﹤0.01% 1736
2015
Q1 		$178K Sell
2,952
-130
-4% -$6.93K ﹤0.01% 1656
2014
Q4 		$165K Buy
3,082
+52
+2% +$2.6K ﹤0.01% 1572
2014
Q3 		$136K Buy
3,030
+224
+8% +$9.52K ﹤0.01% 1429
2014
Q2 		$118K Buy
2,806
+234
+9% +$10K ﹤0.01% 1497
2014
Q1 		$113K Buy
2,572
+105
+4% +$4.94K ﹤0.01% 1440
2013
Q4 		$121K Buy
2,467
+65
+3% +$3.04K ﹤0.01% 1351
2013
Q3 		$99K Sell
2,402
-38
-2% -$1.45K ﹤0.01% 1407
2013
Q2 		$86K Buy
+2,440
New +$80.3K ﹤0.01% 1391

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Ladenburg Thalmann Financial Services's WST Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its West Pharmaceutical (WST) stake by 16% in Q4 2019, buying an estimated $135K and bringing the position to 6,620 shares worth $976K. The position accounts for 0.01% of the portfolio, ranked #1305.

Ladenburg Thalmann Financial Services first reported a position in WST in Q2 2013 and has held it in 27 quarters since. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 6,620 shares of West Pharmaceutical worth $976K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 926 West Pharmaceutical shares in Q4 2019, an estimated $135K.
  • West Pharmaceutical made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1305 holding.
  • Ladenburg Thalmann Financial Services first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.